3rd PREDiCT Tumor Models San Francisco - January 2019

Conference themes
Returning for its 3rd year, PREDiCT: Tumor Models San Francisco remains dedicated to revealing model-based strategies adding immediate value to emerging IO programs.

With new speakers, fresh case studies, and a more interactive format to the agenda, this is your opportunity to plug into a ready-made network of pioneering biotech and developers redefining this area.

Professional congress organizer (PCO)
Hanson Wade

Notes
James Hodge, Deputy Chief Tumor Immunology and Biology, Senior Investigator, Head, Recombinant Vaccine Group, National Cancer Institute, Barbara Joyce- Shaikh, Associate Principal Scientist, Merck and Co, Peter King, and more

https://go.evvnt.com/290403-0?pid=4832

Ms. Kaltrina Kastrati